English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 天
Acura制药公司与AD Pharma修订协议,面临财务挑战
伊利诺伊州PALATINE讯 — Acura制药公司(OTC Market: ACUR)是一家专注于开发防滥用药物的微型制药公司,市值仅为USD 0.05百万。根据最新的SEC文件显示,该公司已与Abuse Deterrent Pharma, LLC(AD Pharma)达成修订协议。尽管该公司股票在过去六个月下跌近79%,但年初至今仍上涨300%。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Sworn in as Canada's PM
Pleads not guilty
Trump signs funding bill
Deportation order blocked
Coffee creamer recall
‘Ted Lasso’ is coming back
Wins longest-ever Iditarod
Laceration hazard recall
Gold rises to new heights
Influencer leaves Australia
Felony gun possession arrest
US launches strikes in Yemen
SK: Massive rallies erupt
Second protester arrested
Top intelligence agency visit
Cuba suffers power outage
Kupp signs with Seahawks
Withdraws nomination
Child abuse images sentence
US expels SA ambassador
Influential WY senator dies
Syed formally resentenced
ISIS leader killed in Iraq
Texas measles outbreak
Permanently shuts route
RU, UKR launch attacks
Consumer sentiment drops
Chiefs sign Tillery
Senate confirmation hearing
Severe weather outbreak
CA man wins $50M over burns
反馈